Nexentis Technologies Inc. (NXTS)
NASDAQ: NXTS · Real-Time Price · USD
4.005
-0.184 (-4.38%)
Apr 8, 2026, 2:47 PM EDT - Market open
Nexentis Technologies Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
5
Market Cap
1.61M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 263.00K | -131.00K | -33.25% |
| Dec 31, 2022 | 394.00K | -44.14K | -10.07% |
| Dec 31, 2021 | 438.14K | 205.87K | 88.63% |
| Dec 31, 2020 | 232.27K | 56.45K | 32.11% |
| Dec 31, 2019 | 175.82K | -250.77K | -58.78% |
| Dec 31, 2018 | 426.59K | 82.66K | 24.04% |
| Dec 31, 2017 | 343.93K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nutrien | 25.95B |
| The Mosaic Company | 12.05B |
| ICL Group | 7.15B |
| CF Industries Holdings | 7.08B |
| FMC Corporation | 3.47B |
| The Scotts Miracle-Gro Company | 3.40B |
| CVR Partners | 606.04M |
| American Vanguard | 515.11M |
NXTS News
- 6 weeks ago - N2OFF, Inc. Provides Early Warning Disclosure - TheNewswire
- 2 months ago - In Spaceflight Conditions: N2OFF‘s MitoCareX Bio Highlights Co-Founder's Innovative Research on Mitochondrial Carriers in Microgravity and Cosmic radiation Conditions - GlobeNewsWire
- 2 months ago - N2OFF: MitoCareX Bio Announces Positive In Vitro Results from Its Mitochondrial Carrier Small Molecule Platform - GlobeNewsWire
- 2 months ago - N2OFF: MitoCareX Bio Spotlights Co-Founder's Pioneering Research on Mitochondrial Carriers in Spaceflight Stress Conditions - GlobeNewsWire
- 3 months ago - N2OFF Advances $340,000 Payment to Gain Better Terms in Flag Solar Energy Initiative, Reflecting Approximately an Additional $1.7 Million in Project Profit Stake - GlobeNewsWire
- 3 months ago - N2OFF Accelerates European Renewable Energy Momentum with Major De-Risking Milestones and Approximately $1.69 Million Value Unlock in Germany and Italy - GlobeNewsWire
- 5 months ago - N2OFF: MitoCareX Identifies Hit Compounds and Targets Preclinical Candidate Nomination - GlobeNewsWire
- 5 months ago - N2OFF Completed Merger with Cancer Drug Discovery Company Targeting Tough-to-Treat Pancreatic and Lung Cancers - GlobeNewsWire